|
US5744500A
(en)
|
1990-01-03 |
1998-04-28 |
Teva Pharmaceutical Industries, Ltd. |
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
|
|
IL118836A
(en)
|
1996-07-11 |
2001-01-11 |
Teva Pharma |
Pharmaceutical compositions comprising s-(-)-n-propargyl-1-aminoindan
|
|
AU2002244247B2
(en)
|
2001-03-01 |
2007-12-13 |
Harbor Biosciences, Inc. |
Use of certain steroids for treatment of blood cell deficiencies
|
|
EP2298315A1
(en)
|
2002-08-28 |
2011-03-23 |
Harbor BioSciences, Inc. |
Therapeutic treatment methods
|
|
EP1565185A4
(en)
*
|
2002-11-07 |
2011-01-05 |
Technion Res & Dev Foundation |
NEUROPROTECTIVE IRON CHELATORS AND PHARMACEUTICAL COMPOSITIONS THEREWITH
|
|
SI1567152T1
(sl)
|
2002-11-15 |
2013-10-30 |
Teva Pharmaceutical Industries Ltd. |
Uporaba rasagilina z riluzolom za zdravljenje amiotrofične lateralne skleroze
|
|
US8097608B2
(en)
*
|
2003-11-25 |
2012-01-17 |
Technion Research And Development Foundation Ltd. |
Methods for treatment of cardiovascular disorders and diseases
|
|
WO2005051371A1
(en)
|
2003-11-25 |
2005-06-09 |
Technion Research & Development Foundation Ltd. |
Compositions and methods for treatment of cardiovascular disorders and diseases
|
|
JP2005232148A
(ja)
*
|
2004-02-03 |
2005-09-02 |
Technion Research & Development Foundation Ltd |
神経保護剤としてプロパルギルアミンの使用
|
|
WO2006014973A2
(en)
*
|
2004-07-26 |
2006-02-09 |
Teva Pharmaceutical Industries, Ltd. |
Pharmaceutical dosage forms including rasagiline
|
|
US20060025446A1
(en)
*
|
2004-07-27 |
2006-02-02 |
Jeffrey Sterling |
Propargyl nitroxides and indanyl nitroxides and their use for the treatment of neurologic diseases and disorders
|
|
EP2471536A1
(en)
|
2004-09-29 |
2012-07-04 |
Harbor BioSciences, Inc. |
Steroid analogs and characterization and treatment methods
|
|
WO2006089164A1
(en)
*
|
2005-02-17 |
2006-08-24 |
Teva Pharmaceutical Industries, Ltd. |
Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
|
|
CA2901244A1
(en)
|
2005-02-23 |
2006-08-31 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline formulations of improved content uniformity
|
|
US8263655B2
(en)
|
2005-10-06 |
2012-09-11 |
Technion Research And Development Foundation Ltd |
Methods for treatment of renal failure
|
|
EP1954667B1
(en)
*
|
2005-11-17 |
2017-02-08 |
Teva Pharmaceutical Industries Ltd |
Methods for isolating propargylated aminoindans
|
|
US7572834B1
(en)
|
2005-12-06 |
2009-08-11 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline formulations and processes for their preparation
|
|
AU2006326642B2
(en)
|
2005-12-09 |
2012-05-03 |
Technion Research And Development Foundation Ltd. |
Use of low-dose ladostigil for neuroprotection
|
|
JP5701485B2
(ja)
|
2006-02-21 |
2015-04-15 |
テバ ファーマシューティカル インダストリーズ リミティド |
多系統萎縮症の治療のためのラサギリンの使用
|
|
TW200744576A
(en)
|
2006-02-24 |
2007-12-16 |
Teva Pharma |
Propargylated aminoindans, processes for preparation, and uses thereof
|
|
CA2646250A1
(en)
|
2006-04-03 |
2007-10-18 |
Teva Pharmaceutical Industries Ltd. |
Use of rasagiline for the treatment of restless legs syndrome
|
|
EP1892233A1
(de)
*
|
2006-08-18 |
2008-02-27 |
Ratiopharm GmbH |
Neue Salze des Wirkstoffs Rasagilin
|
|
ZA200903903B
(en)
*
|
2006-12-14 |
2010-08-25 |
Teva Pharma |
Crystalline solid rasagiline base
|
|
JP5356248B2
(ja)
*
|
2006-12-14 |
2013-12-04 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラサギリンのタンニン酸塩
|
|
EP1987816A1
(de)
*
|
2007-04-30 |
2008-11-05 |
Ratiopharm GmbH |
Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff
|
|
AU2008296908B2
(en)
*
|
2007-09-05 |
2014-01-09 |
Teva Pharmaceutical Industries, Ltd. |
Method of treating glaucoma using rasagiline
|
|
US8188149B2
(en)
*
|
2007-09-17 |
2012-05-29 |
Teva Pharmaceutical Industries, Ltd. |
Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss
|
|
US20090181086A1
(en)
*
|
2008-01-11 |
2009-07-16 |
Muhammad Safadi |
Rasagiline formulations, their preparation and use
|
|
WO2009122351A2
(en)
*
|
2008-04-01 |
2009-10-08 |
Kangwon National University |
Anti-parkinsonian compounds mppe
|
|
WO2009151594A1
(en)
*
|
2008-06-10 |
2009-12-17 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline soft gelatin capsules
|
|
JP2011522892A
(ja)
*
|
2008-06-13 |
2011-08-04 |
テバ ファーマシューティカル インダストリーズ リミティド |
パーキンソン病緩和のためのラサギリン
|
|
AU2009260733B2
(en)
*
|
2008-06-19 |
2015-01-29 |
Teva Pharmaceutical Industries, Ltd. |
Process for purifying rasagiline base
|
|
MX2010013875A
(es)
|
2008-06-19 |
2011-01-20 |
Teva Pharma |
Proceso para preparar y secar base de rasagilina solida.
|
|
US20100189790A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Teva Pharmaceutical Industries, Ltd. |
Delayed release rasagiline formulation
|
|
SI2451771T1
(sl)
|
2009-07-09 |
2014-10-30 |
Ratiopharm Gmbh |
Soli rasagilina in njihovi farmacevtski pripravki
|
|
RU2607595C2
(ru)
|
2010-02-03 |
2017-01-10 |
Фарма Ту Б Лтд. |
Составы разагилина с пролонгированным высвобождением и их применение
|
|
AU2011282716A1
(en)
|
2010-07-27 |
2013-03-14 |
Teva Pharmaceutical Industries Ltd. |
Dispersions of rasagiline citrate
|
|
CA2806740A1
(en)
|
2010-07-27 |
2012-02-02 |
Teva Pharmaceutical Industries Ltd. |
Use of rasagiline for the treatment of olfactory dysfunction
|
|
WO2013055687A2
(en)
|
2011-10-10 |
2013-04-18 |
Teva Pharmaceutical Industries Ltd. |
R(+)-n-formyl-propargyl-aminoindan
|
|
JP2014534197A
(ja)
|
2011-10-10 |
2014-12-18 |
テバ ファーマシューティカル インダストリーズ リミティド |
Ｒ（＋）−ｎ−メチル−プロパルギルアミノインダン
|
|
US9308182B2
(en)
|
2012-08-17 |
2016-04-12 |
Teva Pharmaceutical Industries, Ltd. |
Parenteral formulations of rasagiline
|
|
CN104177611A
(zh)
*
|
2013-05-27 |
2014-12-03 |
韩文毅 |
一种非线性的聚合物及其制备和用途
|
|
CN104177610A
(zh)
*
|
2013-05-27 |
2014-12-03 |
韩文毅 |
一种非线性的聚合物及其制备和用途
|
|
CN111333517A
(zh)
*
|
2018-12-19 |
2020-06-26 |
上海奥博生物医药技术有限公司 |
一种制备雷沙吉兰的改进方法
|